REGNNeutral (ASignal Rank 3/4)

ASignal's 10+ AI agent pipeline rates REGN as Neutral with 77% confidence in the Healthcare sector.

AI Analysis Summary

Regeneron (REGN) presents a mixed investment profile with conflicting signals between valuation, fundamentals, and technicals.

Investment Framework Assessment

Evaluated through three legendary investor frameworks:

  • Warren Buffett (Value Investing): Grade D — 25/100
  • Bill Ackman (Activist Investing): Grade B+ — 71/100
  • Ray Dalio (Macro/Risk Parity): Grade C — 55/100

Consensus: Neutral

Price Intelligence

  • Current price: $751.57
  • Price target: $792.25 (+5.4%)
  • Risk level: high
  • Horizon: medium term

Quality Assessment

  • Balance sheet: concerning
  • Cash flow: fair
  • Competitive moat: intangible assets

Peer Group Analysis

REGN is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.

REGN Neutral Signal — AI Analysis | ASignal